![Tagamet Syrup (Cimetidine)](https://dev.rosemontpharma.com/wp-content/uploads/2023/11/product-placeholder-with-padding.png)
Tagamet Syrup (Cimetidine)
Cimetidine is a histamine H₂ receptor antagonist.
Tagamet Syrup is indicated for:
The treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by Cimetidine has been shown to be beneficial: persistent dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastrointestinal haemorrhage from stress ulceration in critically ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Cimetidine is also recommended in the management of the Zollinger-Ellison syndrome.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Tagamet Syrup. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Tagamet Syrup, what it’s used for and possible side effects. Click below to navigate to the EMC.
Tagamet Syrup (Cimetidine)
![Tagamet Syrup (Cimetidine)](https://dev.rosemontpharma.com/wp-content/uploads/2023/11/product-placeholder-with-padding.png)
Click here for Audio Version | |
Flavour | Peach |
Storage Conditions | Store below 25°C |
Sucrose Free | |
Shelf Life (Closed Bottle) | 3 years |
PIP Code | 251173 |
EAN Code | 5016119171390 |
Sodium Levels | 12.8mg/5ml |
Ethanol Concentration | 118.1mg/5ml |
Downloads
Adverse Drug Events
Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400
![Rosemont Pharmaceuticals - World Map icon](https://dev.rosemontpharma.com/wp-content/uploads/2023/10/Group-490.png)
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
![Rosemont app on a mobile device](https://dev.rosemontpharma.com/wp-content/uploads/2023/10/rosemont-app-phone-image.png)